IFNG and cancer: In late‐stage colon cancer, tumor‐infiltrating hILC1s showed lower frequencies with reduced IFN‐γ production and high levels of inhibitory receptors,33 suggesting that tumor protective hILC1s can become dysfunctional during cancer progression.